Siu Ping Ngok
Director, Advisory, Strategy - PDT
Ping is a life sciences consultant within KPMG Healthcare and Life Sciences (HCLS) Strategy group, with years of experience advising global and regional organizations across the HCLS landscape. His past clients include brand and generic drug manufacturers, biotech companies, start-ups, and provider organizations. He has supported clients across different functional areas such as brand / launch, pricing & access, business development, diagnostic, and new product planning. Prior to consulting, Ping was a research fellow at the Stanford School of Medicine and earned his Ph.D. in Cancer Biology & Molecular Pharmacology from the Mayo Clinic studying drivers of solid and liquid tumors via translational research, next generation sequencing, and modeling.